ArticleFrontiers in oncology2023

Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers.

Elvelyn R Fernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.